Prevalence of metabolic syndrome in Amol and Zahedan, Iran: A population based study

Archives of Iranian Medicine

Volumn 17, Issue 7, 2014, Pages 477-482

  Ostovaneh, Mohammad Reza ^a   Zamani, Farhad ^b   Sharafkhah, Maryam ^a   Ansari Moghaddam, Alireza ^c   Akhavan Khaleghi, Niloofar ^a   Saeedian, Fatemeh Sima ^b   Rohani, Zohreh ^c   Motamed, Nima ^b   Maadi, Mansoreh ^b   Malekzadeh, Reza ^a   Poustchi, Hossein ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Iran; Metabolic syndrome X; Prevalence

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AGE; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENDER; HUMAN; INSULIN RESISTANCE; IRAN; MALE; METABOLIC SYNDROME X; PREVALENCE; WAIST CIRCUMFERENCE; ADOLESCENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MARRIAGE; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTOR; SMOKING; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; IRAN; LOGISTIC MODELS; MALE; MARITAL STATUS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; PREVALENCE; RISK FACTORS; SMOKING; YOUNG ADULT;

EID: 84904200148     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alwan A. Global status report on noncommunicable diseases. 2010; WHO, 2011
2. Olufadi R Byrne C. Clinical and laboratory diagnosis ofthe metabolic syndrome. J Clin Pathol. 2008; 61(6): 697-706
3. Goossens GH. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. PhysiolBehav. 2008; 94(2): 206
4. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49(4): 403-414
5. Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino Jr RB, Wa-genknecht LE, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome. Circulation. 2005; 112(24): 3713-3721
6. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4): 917-923
7. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: A review. Am J Clin Nutr. 2007; 86(3): 836S-842S.
8. Grundy SM, Cleeman JI, Daniels SR Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome-An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17): 2735-2752. doi:10.1161/circulationaha.105.169404
9. Alberti K, Zimmet P, Shaw J. Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetic Med. 2006; 23(5): 469-480
10. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the AT-PIII and the WHO definitions. Diabetes Res Clin Pract. 2007; 77(2): 251
11. Sharifi F, Mousavinasab S, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res. 2009; 2009: 136501. doi: 10.1155/2009/136501
12. Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab. 2010; 7(1): 26
13. Amer Diabet A. Standards of Medical Care in Diabetes-2010. Diabetes Care. 2010; 33: S11-S61. doi:10.2337/dc10-S011
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al.: The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report. JAMA. 2003; 289(19): 2560-2571. doi:10.1001/ jama.289.19.2560
15. Esteghamati A, Ashraf H, Rashidi A, Meysamie A. Waist circumference cut-off points for the diagnosis of metabolic syndrome in Iranian adults. Diabetes Res Clin Pract. 2008; 82(1): 104-107
16. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kellishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: The national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care. 2009; 32(6): 1092-1097
17. Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, et al. Low prevalence of metabolic syndrome and its components in rural Japan. Tohoku J Exp Med. 2008; 216(1): 69-75
18. Ali NS, Khuwaja AK, Nanji K. Retrospective analysis of metabolic syndrome: Prevalence and distribution in executive population in urban Pakistan. Int J Family Med. 2012; 2012: Article ID 649383
19. Kaykhaei MA, Hashemi M, Narouie B, Shikhzadeh A, Jahantigh M, Shirzaei E, et al. Prevalence of Metabolic Syndrome in Adult Population from Zahedan, Southeast Iran. Iran J Public Health. 2012; 41(2): 70-76
20. Criqui M, Wallace R, Heiss G, Mishkel M, Schonfeld G, Jones G. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation. 1980; 62(4 Pt 2): IV70
21. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. NEJM. 2002; 347(19): 1483-1492
22. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319(7224): 1523-1528
23. Tyroler H, Glueck C, Christensen B, Kwiterovich P. Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation. 1980; 62(4 pt 2): IV99-IV107
24. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA. 2002; 287(3): 356-359
25. Saha N. Serum high density lipoprotein cholesterol, apolipoprotein AI, A-II and B levels in Singapore ethnic groups. Atherosclerosis. 1987; 68(1): 117-121.